Skip to main content

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis

Introduction

Fluoroquinolone (FQ) resistance in Mycobacterium tuberculosis can be conferred by mutations in gyrA or gyrB gene. Recent studies suggest that amino acid substitutions in gyrB gene may also play a crucial role in resistance, but genetic studies of these mutations in M. tuberculosis are lacking.

Methods

A total of 100 ofloxacin resistant (OFX r) and 100 OFX sensitive (OFX s) isolates of M.tuberculosis isolates were consecutively selected from routine TB laboratory during 2012-2013. All the isolates were screened for phenotypic OFX r (>2µg/ml) by 1% proportion method and tested for minimal inhibitory concentration by absolute concentration method. Quinolone resistance determining region (QRDR) of gyrA and gyrB genes of 320bp and 428bp respectively were amplified, sequenced and compared with M.tuberculosis H37Rv.

Results

Mutations in the gyrB gene were observed in 5 of the 100 OFX r isolates. The single nucleotide mutation sites were in codons 538, 500, 539 (in two isolates) and 592. In one isolate, a substitution at codon 592 (Pro592Ser) was found as novel mutation outside QRDR region of gyrB gene. Accession nos. of these isolates include; KF509920-KF509922, KC880086 & KC880101. All the isolates showing mutations in gyrB gene also had mutations in gyrA gene. Mutations in gyrA gene were observed in 79% OFX r isolates. No mutation was observed in gyrB gene of OFX s isolates.

Conclusion

No OFX r isolates had shown mutation in the gyrB gene in the absence of gyrA gene mutation. The role of the gyrB gene mutation in conferring resistance to OFX in M.tuberculosis needs to be studied further.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amita Jain.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Singh, P., Jain, A., Dixit, P. et al. A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis. BMC Infect Dis 14, O14 (2014). https://doi.org/10.1186/1471-2334-14-S3-O14

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1471-2334-14-S3-O14

Keywords

  • Codon
  • Tuberculosis
  • Minimal Inhibitory Concentration
  • Mycobacterium Tuberculosis
  • Fluoroquinolone